Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Myriad Genetics

Explore full profile

A leading personalized medicine company dedicated to being a trusted advisor transforming patients' lives worldwide with pioneering molecular diagnostics.

Salt Lake City, United StatesFounded 1991Biotech & Life Sciences
Valuation $365M Market cap · Aug/2026
Revenue $853M Latest reported FY
EBITDA $37M Latest reported FY

At a glance

Status
Listed
Founded
1991
Headquarters
Salt Lake City, United States
Listing
IPO 1995
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • University of Utah

Talent

Book a demo to see the people
Employees mapped 2,929 incl. 16 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
19 countries with
team presence
🇺🇸 United States97.5%
🇩🇪 Germany0.4%
🇮🇳 India0.3%
🇬🇧 United Kingdom0.3%
🇫🇷 France0.2%
Top 5 of 19 shown
Web traffic by country
250K monthly visits
across markets
🇺🇸 United States85.1%
🇮🇳 India2.1%
🇨🇦 Canada1.9%
🇦🇺 Australia1.9%
🇵🇭 Philippines1%
Top 5 markets shown

Patents

Estimated portfolio value
$98M

85 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Myriad Genetics was the backer or acquirer, 2009–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across Myriad Genetics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Myriad Genetics's portfolio, mapped.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Myriad Genetics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Myriad Genetics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles